- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07542431
Auswirkung der Hundeadoption und -ausbildung bei Veteranen mit posttraumatischen Stresssymptomen und/oder anderen psychischen Erkrankungen (VCRM)
Bewertung biopsychosozialer Indikatoren in Verbindung mit der Behandlungswirkung von Hundeeinsätzen bei Veteranen mit posttraumatischen Belastungssymptomen und/oder anderen psychischen Erkrankungen
The goal of this single-arm study is to learn if a dog adoption and training program can treat, prevent in [describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers]. The main questions it aims to answer are:
- Does the dog adoption and training program decrease posttraumatic stress symptoms in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease stress and improve psychosocial health in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease inflammation, increase oxytocin, and change the structure and resting-state function of specific brain regions in veterans with self-reported posttraumatic stress symptoms?
Participants will:
- Attend eight one-hour professional dog training sessions within a 10-week period.
- Visit the clinical research unit four times during the study for data collection.
Studienübersicht
Status
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Beth A Pratt, PhD
- Telefonnummer: 561-297-4227
- E-Mail: bpratt4@health.fau.edu
Studienorte
-
-
Florida
-
Boca Raton, Florida, Vereinigte Staaten, 33431
- Rekrutierung
- Florida Atlantic University
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Military veteran with self-reported posttraumatic stress symptoms and/or other mental health conditions
- Over 18 years of age
- Applied and approved to adopt a shelter dog for training through the Humane Society of Broward County in Fort Lauderdale, Florida
- English speaker (written and spoken)
- Home internet access via tablet, computer or smartphone.
Exclusion Criteria:
- Fear of dogs
- Allergies to pet dander
- Uncorrected hearing or visual impairment.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Study Intervention
Within-subjects design |
Eight, one-hour professional dog training sessions over 8-10 weeks |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in self-reported posttraumatic stress disorder (PTSD) symptoms from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) is a 20-item self-report measure of PTSD symptoms with scores ranging from 0 to 80. |
From enrollment to 4 weeks post-intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in depression symptom severity from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptoms with scores ranging from 0 to 27. |
From enrollment to 4 weeks post-intervention
|
|
Change in anxiety symptom severity from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Generalized Anxiety Disorder-7 (GAD-7) is a is a 7-item self-report measure of anxiety symptoms with scores ranging from 0 to 21. |
From enrollment to 4 weeks post-intervention
|
|
Change in perceived stress severity from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure of perceived stress symptoms with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in sleep disturbance from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Patient-Reported Outcomes Measurement Information System Sleep 8b (PROMIS Sleep 8b) is an 8-item self-report measure of sleep quality over the past 7 days with raw scores ranging from 8 to 40 and standardized T scores ranging from 28.9 to 76.5. |
From enrollment to 4 weeks post-intervention
|
|
Change in loneliness from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Revised UCLA Loneliness Scale is a 20-item self-report measure of loneliness with scores ranging from 20 to 80. |
From enrollment to 4 weeks post-intervention
|
|
Change in alcohol use from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Alcohol Use Disorder Identification Test (AUDIT) is a 10-item self-report measure of alcohol use with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis use from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Cannabis Use Disorder Identification Test (CUDIT) is an 8-item self-report measure of cannabis use with scores ranging from 0 to 32. |
From enrollment to 4 weeks post-intervention
|
|
Change in salivary oxytocin levels from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Oxytocin is a neurotransmitter that plays a role in determining social behavior. Salivary oxytocin levels range from 6.4-1000 pg/mL. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-1 beta (IL-1β) from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
IL-1β is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-1β is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-6 (IL-6) from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
IL-6 is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-6 is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in tumor necrosis factor-alpha (TNF-alpha) from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
TNF-alpha is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. TNF-alpha is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in alcohol demand for participants who answer "yes" to alcohol consumption in the AUDIT measure from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Alcohol Purchase Task is a tool to measure alcohol demand by asking individuals how many drinks they would consume at prices ranging from free to high, using behavioral economic indices for scoring. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis demand for participants who answer "yes" to cannabis use from baseline to 4 weeks post-intervention
Zeitfenster: From enrollment to 4 weeks post-intervention
|
Cannabis Purchase Task is a tool to measure cannabis demand by assessing how much an individual purchases at increasing prices. |
From enrollment to 4 weeks post-intervention
|
|
Change in Magnetic Resonance Imaging (MRI) biomarkers from baseline to 4 weeks post-intervention
Zeitfenster: Pre-intervention and 4 weeks post-intervention
|
Optional participation in an MRI to detect changes in the structure and resting-state function of specific brain regions (anterior cingulate, amygdala, hippocampus, and insula) |
Pre-intervention and 4 weeks post-intervention
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Beth A Pratt, PhD, Florida Atlantic University
- Hauptermittler: Cheryl A Krause-Parello, PhD, Florida Atlantic University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- IRB2310227
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .